title: Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.
authors.forename: Helmut
authors.initials: H
authors.lastname: Neumann
authors.forename: Antal
authors.initials: A
authors.lastname: Csepregi
authors.forename: Michael
authors.initials: M
authors.lastname: Sailer
authors.forename: Peter
authors.initials: P
authors.lastname: Malfertheiner
mesh_terms: D000208:Acute Disease / Q000628:therapy; D000276:Adjuvants, Immunologic / Q000009:adverse effects; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000974:Antibodies, Antinuclear / Q000097:blood / Q000276:immunology; D019819:Budesonide / Q000008:administration & dosage; D004357:Drug Synergism; D000068717:Glatiramer Acetate; D019693:Hepatitis, Autoimmune / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000009:adverse effects; D008099:Liver / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D008297:Male; D008353:Mannitol / Q000009:adverse effects; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D010455:Peptides / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D000974:Antibodies, Antinuclear; D010455:Peptides; D000068576:Interferon beta-1b; D008353:Mannitol; D019819:Budesonide; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D009173:Mycophenolic Acid